Advertisement Sinclair Pharma licenses mouth ulcer product in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sinclair Pharma licenses mouth ulcer product in US

Sinclair Pharma has licensed the US rights of its flagship mouth ulcer product, Aloclair Spray, to Omni Preventive Care, a 3M ESPE Company.

Under the terms of the deal, Sinclair will supply Aloclair Spray to Omni Preventive Care, which will be responsible for the marketing and distribution of the product in the US market. Omni will have the exclusive rights to promote Aloclair Spray to dental professionals and consumers. Sales are expected to commence within this financial year

Aloclair Spray has marketing clearance in the US and the EU, and Sinclair has marketing partners for the Aloclair range in 29 countries worldwide.

“We are confident that Omni will establish Aloclair Spray as a successful new brand in the US. This deal consolidates our strong network of marketing partners for our product portfolio, in the US and 60 other countries around the world,” said Dr Michael Flynn, CEO of Sinclair Pharma.